DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting

    NEXT STORY
    LifeStyle
    PREV STORY
    New data at AAN reinforce Novartis commitment to transforming the lives of people of all ages who live with neurological conditions
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Lateral Flow Assays Market Size is Expected to Reach $13.35 Billion by 2030: Says AMR

    author_avatar
    NASDAQ Market News

    NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

    WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the ...

    author_avatar
    NASDAQ Market News

    Generex Biotechnology Appoints Independent Director Carol Nacy, PhD to the NuGenerex Immuno-Oncology Board of Directors

    author_avatar
    NASDAQ Market News